MEDIA RELEASEDottikon, April 14, 2023

Ad hoc announcement pursuant to article 53 LR of the SIX Swiss Exchange

DOTTIKON ES By-Laws Revision - Introduction of Capital Band and Use of Electronic Means

Dottikon, Switzerland, April 14, 2023 - DOTTIKON ES Group, positioned as strategic development and manufacturing partner and specialized in the area of hazardous reactions and the exclusive synthesis of active pharmaceutical ingredients (API) and fine chemicals, will propose the revision of its By-Laws at an Extraordinary General Meeting with introduction of a capital band and possibility to use electronic means for General Meetings without a venue as well as for votings and elections.

The new stock corporation law entered into force on January 1, 2023. Among other things, the revised Swiss Code of Obligations adapts Swiss corporate law to today's economic needs of companies and strenghtens shareholder rights, introduces more flexibility with regard to capital, and modernizes the way General Meetings can be held.

The Board of Directors has decided, as a result of the comprehensive revision of DOTTIKON ES HOLDING AG's By-Laws, to propose the alignment to the new applicable statutory requirements at an Extraordinary General Meeting to be held in Baden (Aargau, Switzerland) on May 25, 2023.

In addition to the adaptation of the By-Laws to the new and updated legal provisions, in particular the possibility of holding a General Meeting without a venue in impossible or difficult cases as well as voting and elections by electronic means for the purpose of efficient determination of the exact voting results shall be introduced. The introduction of a capital band from today's fully paid-in share capital (lower limit) up to CHF 160'989.46 (upper limit) for five years with the possibility for the Board of Directors to restrict subscription rights shall allow increased flexibility for rapid capital increases in a dynamic market environment for accelerated growth.

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste sustainably. The versatile technology and equipment portfolio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes. DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development and management, clear and transparent data and process documentation, and close customer communication.

Dottikon ES Holding AG

P.O. Box, 5605 Dottikon, Switzerland, Tel +41 56 616 81 11, investor-relations@dottikon.com, www.dottikon.com

DOTTIKON ES HOLDING AG is listed on the SIX Swiss Exchange. Symbol: DESN

Security number: 58258171

ISIN: CH0582581713

For further information please contact

Markus Blocher, Ph.D.

CEO

Dottikon ES Holding AG

Tel +41 56 616 82 01 investor-relations@dottikon.com

Dottikon ES Holding AG

P.O. Box, 5605 Dottikon, Switzerland, Tel +41 56 616 81 11, investor-relations@dottikon.com, www.dottikon.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Dottikon ES Holding AG published this content on 14 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 April 2023 04:55:07 UTC.